Altre lingue Xtacy Therapeutics Corp. Deutsche Boerse AG

Azioni

TT5

CA98423G1072

Mercato chiuso - Deutsche Boerse AG Altri mercati azionari 08:05:03 15/05/2024			Variaz. 5gg	Var. 1 gen.
0,0205 ^EUR	-2,38%		+95,24%	+64,00%

17/04	Xtacy Therapeutics Corp. riporta i risultati degli utili per il primo trimestre conclusosi il 31 dicembre 2023	CI
15/04	Xtacy Therapeutics Corp. riporta i risultati degli utili per l'intero anno conclusosi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Xtacy Therapeutics Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023	17/04
Xtacy Therapeutics Corp. Reports Earnings Results for the Full Year Ended September 30, 2023	15/04
Xtacy Therapeutics Corp. Expands MDMA Platform Pharmaceutical Grade Psychedelic Solutions to Solve Unmet Medical Needs	06/12
XTACY Therapeutics Announces Debt Settlement	05/10/23
Global Wellness Strategies Inc. will Change its Name to XTACY Therapeutics Corp	25/09/23
Global Wellness Strategies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23/08/23
Global Wellness Strategies : Voting Instruction Form (“VIF”) – Annual General Meeting to be held on Wednesday, August 16, 2023	17/07/23
Global Wellness Strategies : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON AUGUST 16, 2023	17/07/23
Global Wellness Strategies : GWS NEWS RELEASE	18/04/23
Global Wellness Strategies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	18/04/23
Global Wellness Strategies Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	03/04/23
Global Wellness Strategies Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	29/03/23
Global Wellness Strategies Inc. Auditor Raises 'Going Concern' Doubt	29/03/23
Global Wellness Strategies : Files Annual Statements September 2022	29/03/23
Global Wellness Strategies Inc. Announces Formation of Wholly Owned Pharma Subsidiary Focused on Clinical Trials	17/11/22
Global Wellness Strategies Effervescent Cannabis Products Approved to Launch GWS Achieves Major Milestone Partnering with Hempsana Holdings	31/10/22
Global Wellness Strategies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	02/09/22
Global Wellness Strategies Inc. Signs Custom Manufacturing Agreement with Hempsana Holdings	02/08/22
Global Wellness Strategies : Information Circular	29/07/22
Global Wellness Strategies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	01/06/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Xtacy Therapeutics Corp. Deutsche Boerse AG

Azioni

TT5

CA98423G1072

Altre lingue

Filtri